T3U-ALPHA Injection

T3U-ALPHA contains Thymosin Alpha 1, a naturally occurring thymic peptide that plays a key role in regulating and enhancing the immune response. It is used as an immunotherapeutic agent in the management of chronic viral infections, hepatitis B and C, sepsis, HIV/AIDS, and cancer-related immunosuppression.

Description

Composition (Per Pack):

  • Thymosin Alpha 1 – 1.6 mg (Lyophilized powder)

  • Sterile Water for Injection I.P. – 1 ml (Ampoule for reconstitution)
    Form: Lyophilized powder for injection
    Route of Administration: Subcutaneous or Intramuscular injection
    Pack Size: 1 vial + 1 ampoule
    Category: Immunomodulator | Biologic Therapy | Viral Hepatitis Support


Product Description:

T3U-ALPHA contains Thymosin Alpha 1, a naturally occurring thymic peptide that plays a key role in regulating and enhancing the immune response. It is used as an immunotherapeutic agent in the management of chronic viral infections, hepatitis B and C, sepsis, HIV/AIDS, and cancer-related immunosuppression.

T3U-ALPHA boosts T-cell function, enhances natural killer (NK) cell activity, and improves host immune surveillance, especially in immunocompromised patients.


Key Benefits:

  • Enhances cell-mediated immunity in immunocompromised patients

  • Adjuvant therapy in chronic hepatitis B & C, sepsis, and malignancies

  • Promotes faster recovery during or after viral infections

  • Safe and well-tolerated, with minimal adverse effects


How It Works:

Thymosin Alpha 1 acts on T lymphocytes, boosting their ability to recognize and respond to infections and tumor cells. It also enhances the activity of cytotoxic T cells, dendritic cells, and interferon production, making it a powerful immunorestorative agent.

It is especially effective in restoring immune balance in patients with chronic viral infections, cancer, or severe infections requiring immune support.


How to Use:

  • Reconstitute the lyophilized vial with 1 ml of the provided sterile water

  • Administer subcutaneously or intramuscularly, as directed by the physician

  • Standard dosage and duration vary depending on condition (e.g., 1.6 mg twice weekly for 6–12 weeks in viral hepatitis)

  • To be administered only under the supervision of a qualified healthcare professional


Safety Advice:

  • Generally well-tolerated with a good safety profile

  • Monitor liver function and overall immune response during prolonged therapy

  • Use with caution in patients with autoimmune conditions

  • Not recommended in pregnancy unless clearly indicated


Precautions:

  • Do not use if the solution appears cloudy or contains particles after reconstitution

  • Store in a refrigerator (2°C – 8°C); do not freeze

  • Use reconstituted solution immediately or within recommended time as per label

  • Avoid abrupt discontinuation without physician guidance

  • Not for self-administration without medical advice

Reviews

There are no reviews yet.

Be the first to review “T3U-ALPHA Injection”

Your email address will not be published. Required fields are marked *